Compuage Infocom Ltd (COMPUAGE) will issue Right Entitlements (RE’s) to anyone who holds its shares as of November 14, 2022 (record date). These REs will be temporarily traded on the stock exchanges and will then be extinguished. You can either use the REs to apply for the rights shares of Compuage Infocom Ltd or you can sell them in the market. You can check the announcement from the company here.
You will be eligible to receive Rights Entitlements (REs) if you have bought the shares on or before November 14, 2022. The ex-date is November 14, 2022.
|Ex-Date||November 14, 2022|
|Record Date||November 14, 2022|
|Issue Price||₹ 20|
|Issue Period||November 23, 2022 to December 2, 2022|
|RE Trading Period||November 23, 2022 to November 29, 2022|
|Tentative Date of Allotment||December 13, 2022|
|Tentative Date of Listing||December 21, 2022|
Once you either receive the REs from the company or purchase them from the market, you can apply for the rights shares using Netbanking ASBA or offline by submitting an Application Form to the nearest branch of SCSB (Self Certified Syndicate Bank) . You can check the process in this post .
You will need to enter your demat account’s Beneficiary Owner ID which is a 16-digit number while applying for the rights issue.
The option to apply for rights shares through the RTAs portal is not available for this rights issue.
If you face any difficulties applying for the rights issue, you can get in touch with the RTA at [email protected] or at +91 81081 14949.
Your REs will lapse and you will lose the premium paid to acquire them. The RE will be in the form of temporary demat securities which will lapse if not renounced/exercised once the trading window is closed.
In case you have bought REs but don’t have shares, you’re still eligible for the rights issue. You may apply for the rights shares either through the RTA’s portal or via net banking ASBA if your bank allows it. If you don’t take any action, and let the REs remain in your Zerodha account, they will lapse after the issue.
You can read more FAQ’s on Rights Issue and Rights Entitlements here.